Cardiogen vs Cortagen
Moderate Research vs Moderate Research
compatible Part of Khavinson bioregulator family; targets different tissue.
Molecular Data
Cardiogen Cortagen
Weight 460 Da 416 Da
Half-life Minutes (short peptide); effects persist via epigenetic changes Minutes (short peptide); effects persist via epigenetic changes
Chain 4 amino acids 4 amino acids
Type Tetrapeptide bioregulator Tetrapeptide bioregulator
Key Benefits
Cardiogen
01 Supports cardiac tissue repair and regeneration
02 Regulates cardiovascular gene expression
03 Improves myocardial function
04 May support post-cardiac event recovery
05 Epigenetic mechanism for targeted action
06 Works at DNA/nuclear level
07 Part of comprehensive anti-aging protocols
08 Well-researched Khavinson peptide
Cortagen
01 Regulates central nervous system function
02 Powerful anti-inflammatory effects in brain
03 Supports nerve regeneration
04 Restores oxidative balance
05 Stimulates interleukin-2 expression
06 Reduces autoimmune reactions
07 Beneficial after ischemic brain injury
08 Modulates gene expression in neural tissue
Dosing Protocols
Cardiogen
10-20 mg daily / Once daily for 10-20 consecutive days
Research protocol 10 mg Daily for 10 days
Cortagen
10-20 mg daily / Once daily for 10-20 consecutive days
Research protocol 10 mg Daily for 10 days
Side Effects
Cardiogen
Generally well-tolerated
Minimal side effects reported
Cortagen
Generally well-tolerated
Minimal side effects reported
Contraindications
Active cardiac emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Active neurological emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Research Evidence
Cardiogen Cortagen
Status Moderate Research Moderate Research
References 3 studies 4 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.